---
schema_version: "secwatch.filing_event.v1"
accession: "0001615219-23-000055"
form_type: "8-K"
ticker: "DCOY"
cik: "0001615219"
company_name: "Decoy Therapeutics Inc."
filed_at: "2023-06-15T23:59:59+00:00"
generated_at: "2026-06-14T00:15:25.466601+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Stockholders approve amended stock purchase plan adding 125,000 shares at 2023 annual meeting

## Summary
- All three Class II director nominees (David Arthur, Bruce McCreedy, Jonathan Lieber) elected with over 267,000 votes each.
- Amended ESPP approved: reserve increased by 125,000 shares, with annual automatic increase (2% or 75k shares) through 2028.
- Non-binding advisory vote on executive compensation approved with 216,044 for, 85,774 against.
- Ratification of Ernst & Young as auditor for FY2023 approved with 913,353 for.

## SEC filing metadata
- accession: 0001615219-23-000055
- form_type: 8-K
- ticker: DCOY
- cik: 0001615219
- company_name: Decoy Therapeutics Inc.
- filed_at: 2023-06-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1615219/000161521923000055/0001615219-23-000055-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1615219/000161521923000055/flks-20230614.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001615219-23-000055
- JSON: https://secwatch.observer/filing/0001615219-23-000055.json
- Plain text: https://secwatch.observer/filing/0001615219-23-000055.txt

## Key facts
- Shareholder Votes
  Decoy Therapeutics Inc. shareholders approved Non-binding advisory vote on compensation of named executive officers at the 2023-06-14 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-06-14
  source text: 3. Proposal to provide a non-binding advisory vote on the compensation of the Company’s named executive officers as disclosed in the Proxy Statement: Votes For Votes Against Abstentions Broker Non-Votes 216,044 85,774 12,655 727,170
  evidence_url: https://www.sec.gov/Archives/edgar/data/1615219/000161521923000055/0001615219-23-000055-index.htm
- Shareholder Votes
  Decoy Therapeutics Inc. shareholders approved Election of three Class II directors at the 2023-06-14 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-14
  source text: 1. Proposal to elect three Class II directors to serve until the 2026 annual meeting or until their successors are duly elected and qualified: Nominees Votes For Votes Against Abstentions Broker Non-Votes David J. Arthur 270,248 632 43,593 727,170 Bruce J. McCreedy 267,578 641 46,254 727,170 Jonathan Lieber 269,684 547 44,242 727,170
  evidence_url: https://www.sec.gov/Archives/edgar/data/1615219/000161521923000055/0001615219-23-000055-index.htm
- Shareholder Votes
  Decoy Therapeutics Inc. shareholders approved Approval of Amended and Restated Salarius Pharmaceuticals, Inc. 2015 Employee Stock Purchase Plan at the 2023-06-14 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2023-06-14
  source text: 2. Proposal to approve the Amended and Restated Salarius Pharmaceuticals, Inc. 2015 Employee Stock Purchase Plan: Votes For Votes Against Abstentions Broker Non-Votes 224,289 74,630 15,554 727,170
  evidence_url: https://www.sec.gov/Archives/edgar/data/1615219/000161521923000055/0001615219-23-000055-index.htm
- Shareholder Votes
  Decoy Therapeutics Inc. shareholders approved Ratification of appointment of Ernst & Young LLP as independent registered public accounting firm at the 2023-06-14 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-14
  source text: 4. Proposal to ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023: Votes For Votes Against Abstentions 913,353 103,072 25,218
  evidence_url: https://www.sec.gov/Archives/edgar/data/1615219/000161521923000055/0001615219-23-000055-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.